The FDA’s refusal to review Moderna’s mRNA flu vaccine
Stat News • 2/12/2026 – 2/13/2026
Summary
The FDA has refused to review Moderna’s mRNA flu vaccine. This decision has sparked controversy, as discussed on "The Readout LOUD."
Advertisement
Lindy Score Breakdown (V4.2)
51d
Age
1
Sources
from cluster
1206
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1206/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1206/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 50 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: FDA’s evolving view of what makes a ‘breakthrough’ device
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Stat News • 2 days ago
Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk
Stat News • 2 days ago
STAT reporter goes up against radiologists to spot deepfake X-rays
Stat News • 2 days ago
CDC stops testing for rabies, pox viruses
Stat News • 2 days ago
STAT+: ‘Takeover Tuesday’ saves biotech’s quarter
Stat News • 2 days ago
STAT+: Makary marks one year at FDA with focus on achievements in speech to staff
Stat News • 2 days ago
STAT+: Large AI scribe study finds modest time savings, inconsistent use
Stat News • 2 days ago
STAT+: Biotech investors’ plea to Trump, and a busy M&A week
Stat News • 1 day ago
Opinion: My patient would rather take a peptide than a statin. That reveals an uncomfortable truth in medicine
Stat News • 1 day ago
Anti-Lindy Similar stories
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 5 days ago